Survival With β‐Adrenergic Suppression After Lung Transplantation
Open Access
- 16 June 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (12) , e047053
Abstract
Background: Survival following lung transplant (LT) surgery presents an ongoing challenge, and adverse LT outcomes are linked to cardiac arrhythmias. Current guidelines indicate that the role of β‐adrenergic suppression (BAS) after LT remains unclear. Methods: This retrospective observational study included adult patients who underwent LT at the University of Florida between 2016 and 2021. Their pre‐ and post‐LT antiarrhythmic medication use was correlated with long‐term survival after a 10‐day post‐LT blanking window. Results: The LT recipients (N=299) had a mean age of 60±11 years, 45% were women, and mean body mass index was 26±6 kg/m 2 . Available mean follow‐up was 4.5±1.9 years. The primary analysis included 299 patients, of whom 209 (70%) were prescribed BAS. Prescription of BAS after LT correlated with prolonged survival, even after adjusting for potential confounders ( P =0.008). A comparable survival benefit was observed in patients who continued BAS from pre‐LT to those who were newly initiated on BAS after LT, relative to patients not receiving BAS ( P =0.03 and P =0.03, respectively). No survival benefit was observed for other classes of antiarrhythmic drugs used after LT. Conclusions: This large, retrospective, single‐center study identified a correlation between BAS prescriptions and prolonged survival following LT. This association applied to both patients initiating BAS after transplant and those continuing preexisting BAS therapy. These findings underscore the promise of BAS in this population, and further prospective studies are warranted to confirm the beneficial role of BAS after LT.Keywords
This publication has 22 references indexed in Scilit:
- The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 2025 Annual Report of Heart and Lung TransplantationThe Journal of Heart and Lung Transplantation, 2025
- Incidence of arrhythmias in chronic obstructive pulmonary disease, obstructive sleep apnea, and overlap syndrome: A retrospective cohort studyHeart Rhythm, 2025
- Chronic obstructive pulmonary disease as a risk factor for ventricular arrhythmias independent of left ventricular functionHeart Rhythm, 2018
- Chronic obstructive pulmonary disease and ventricular arrhythmia—Association or causation?Heart Rhythm, 2017
- Comprehensive Care of the Lung Transplant PatientChest, 2017
- Contemporary analysis of incidence of post-operative atrial fibrillation, its predictors, and association with clinical outcomes in lung transplantationThe Journal of Heart and Lung Transplantation, 2015
- Relation of Chronic Obstructive Pulmonary Disease to Atrial and Ventricular ArrhythmiasThe American Journal of Cardiology, 2014
- Impact of previous cardiovascular disease on the outcome of lung transplantationThe Journal of Heart and Lung Transplantation, 2010
- A Comparison of Atrial Arrhythmias After Heart or Double-Lung Transplantation at a Single CenterJACC, 2009
- Cardioselective beta-blockers for chronic obstructive pulmonary diseaseCochrane Database of Systematic Reviews, 2005